SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?


To: lazarre who wrote (111)3/31/1998 11:06:00 AM
From: Anthony Wong  Read Replies (1) | Respond to of 642
 
LLY will bounce back to $65 pretty soon. Centocor has been strong both yesterday and today after releasing data over the weekend that its blood clot-fighting drug, ReoPro, reduced complications in heart patients receiving stents. Centocor has been upgraded because of ReoPro. LLY is their marketing partner for this drug; this Centocor news is good news for LLY. I saw many 100,000 blocks of LLY traded this morning. I was surprized when the stock didn't react yesterday.